Cognes · 6 hours ago
Member of the Board of Advisors
United States
Part-time
Remote
Director/Executive
10+ years expCognes Medical Solutions is building a smartphone-based, non-invasive screening and monitoring platform for dementia detection. They are seeking senior neurologists, psychiatrists, physicians, clinical researchers, and healthcare executives to join their Board of Advisors to support scientific validation, adoption, and capital formation.
Artificial Intelligence (AI)Health DiagnosticsMobile AppsSoftware
Hiring Manager
Sandra Challma
Responsibilities
Contribute strategically rather than operationally
Support clinical validation and evidence-generation strategy
Advise on trial design, endpoints, and protocol optimization
Inform research-use and early clinical adoption pathways
Guide regulatory sequencing (research-use → CE/FDA)
Contribute to health-economic and system-level positioning
Facilitate strategic partnerships across academia, pharma, CROs, and healthcare systems
Define optimal clinical and research use cases for early cognitive screening
Inform trial design, study endpoints, and longitudinal monitoring strategies
Advise on integration into research, memory-clinic, and specialty-care workflows
Support regulatory, ethics, and compliance strategy development
Inform commercialization sequencing across research, pharma, and healthcare markets
Provide strategic input on global adoption and expansion priorities
Qualification
Required
Familiarity with clinical research, diagnostics, or regulated healthcare environments
Comfort providing strategic guidance rather than hands-on execution
Interest in advancing early detection and improving dementia outcomes
Willingness to commit 1–2 hours per month for advisory engagement
Preferred
10+ years of experience in one or more relevant domains
Benefits
Advisory equity or equity-linked incentives, aligned with contribution and engagement
Early access to Cognes’ current Seed financing round, alongside strategic and institutional investors
The opportunity to participate as a physician, researcher, or healthcare-executive investor, based on individual interest and eligibility
Company
Cognes
Cognes is developing a scalable, self-administered & non-invasive dementia screening method through a smartphone app utilizing machine-learning technology.
2-10 employees
Funding
Current Stage
Early StageCompany data provided by crunchbase